• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Hypoxia Preserves Therapeutic Activity in Long-Term Passaged Stem Cells

by
November 12, 2026
in Biology
Reading Time: 6 mins read
0
Hypoxia Preserves Therapeutic Activity in Long-Term Passaged Stem Cells

Hypoxia Preserves Therapeutic Activity in Long-Term Passaged Stem Cells

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Published in Biological Research, this study provides the first in vivo evidence that low-oxygen culture environments can maintain the functional potency of stem cells even after extensive serial passaging, a critical challenge for the large-scale production of regenerative therapies.

Mesenchymal stem cells are widely regarded as promising candidates for tissue engineering and regenerative medicine due to their self-renewal capacity and multipotency. However, their clinical application is often limited by the rapid onset of cellular senescence during ex vivo expansion. When MSCs are cultured in standard laboratory conditions, which typically involve oxygen concentrations of approximately 20% to 21%, they eventually reach the Hayflick limit, a state of permanent growth arrest accompanied by a loss of differentiation potential and reduced therapeutic value. This phenomenon poses a significant barrier to the manufacturing of high-quality cell therapies required for clinical use.

The study aimed to systematically evaluate how different oxygen tensions modulate the aging and function of hUC-MSCs. The research team hypothesized that conventional normoxic culture conditions represent a non-physiological hyperoxic state relative to the native tissue niches, where oxygen levels typically range from 2% to 10%. By comparing cells maintained under normoxic (20% O2) and hypoxic (5% O2) conditions, the investigators sought to determine whether sustained hypoxia could mitigate the adverse effects of serial passaging on cellular integrity and therapeutic capacity.

In the in vitro phase of the study, hUC-MSCs were subjected to continuous passaging until senescence occurred. The researchers analyzed proliferation, cell cycle distribution, apoptosis, and senescence biomarkers across serially expanded populations. The results indicated that cells cultured under hypoxic conditions retained enhanced adipogenic and osteogenic differentiation potential, along with superior proliferative capacity, through at least 16 passages. In contrast, normoxic cells exhibited near-complete proliferative arrest by passage 16, characterized by significant accumulation in the G0/G1 phase of the cell cycle and a marked decline in the expression of the proliferation marker Ki67.

Hypoxic culture also attenuated markers of cellular stress and senescence. The study found that hypoxia suppressed DNA damage, as evidenced by lower levels of the oxidative damage marker 8-OH guanine, and reduced the secretion of senescence-associated secretory phenotype (SASP) factors, including interleukin-6, interleukin-8, and transforming growth factor-beta. Furthermore, hypoxic conditions decreased apoptosis rates and preserved telomere length more effectively than normoxic conditions, partially through the upregulation of the telomerase catalytic subunit hTERT. These findings suggest that hypoxia helps maintain genomic stability and delays the onset of replicative senescence during long-term expansion.

To assess the physiological relevance of these in vitro observations, the researchers established a type 2 diabetic nephropathy mouse model using a combination of a high-fat diet and streptozotocin injection. Mice were randomly assigned to groups receiving either control treatments or systemic transplantation of hUC-MSCs from different passage numbers and oxygen conditions. The therapeutic efficacy was evaluated by measuring renal functional recovery and histopathological changes in the kidneys, including serum creatinine, blood urea nitrogen, and 24-hour urinary protein levels.

The in vivo results demonstrated a clear oxygen-dependence in the therapeutic efficacy of high-passage cells. While both hypoxic and normoxic low-passage cells improved renal function, the therapeutic effect of high-passage (P16) cells varied significantly based on the culture environment. Mice receiving hypoxic P16 hUC-MSCs showed a 34.63% reduction in serum creatinine, a 45.12% reduction in blood urea nitrogen, and an 81.57% decrease in 24-hour proteinuria compared to untreated diabetic controls. In stark contrast, mice treated with normoxic P16 hUC-MSCs exhibited no significant therapeutic benefit, indicating that the cells had lost their reparative capacity under standard culture conditions.

Histological and ultrastructural analyses further supported these functional findings. Kidneys from mice treated with hypoxic high-passage cells showed markedly reduced inflammatory cell infiltration, glomerular enlargement, and collagen deposition compared to those treated with normoxic high-passage cells. Transmission electron microscopy revealed that hypoxic cell treatment restored near-normal glomerular basement membrane thickness and podocyte foot process architecture, whereas normoxic treatment resulted in persistent structural abnormalities. These observations suggest that hypoxia preserves the anti-inflammatory and anti-fibrotic properties of the stem cells, enabling them to effectively repair damaged renal tissue.

Transcriptomic profiling of the kidney tissues provided insights into the molecular mechanisms underlying the observed therapeutic differences. RNA sequencing identified significant downregulation of inflammatory and fibrosis-related genes, such as Col1a1 and Tnfsf10, in mice treated with hypoxic high-passage cells. Conversely, genes associated with cellular homeostasis were upregulated. Pathway enrichment analysis highlighted the suppression of NF-kB signaling and extracellular matrix organization pathways, indicating that hypoxic culture conditions help maintain a transcriptional profile conducive to tissue repair and metabolic homeostasis in the injured diabetic kidney.

The study also investigated the biodistribution of the transplanted cells using in vivo small animal imaging. CM-DiL-labeled hUC-MSCs were infused intravenously, and fluorescence intensity was monitored over one week. The results showed peak fluorescence in the kidneys at 24 hours post-injection, with significantly higher signal intensity in diabetic kidneys compared to healthy controls.

Despite the promising results, the study has certain limitations. The in vivo experiments were conducted in a mouse model, and the translation of these findings to human clinical applications requires further validation. Additionally, while the study provides strong evidence for the benefits of hypoxia in preserving cell function, the precise mechanisms by which hypoxia modulates the paracrine and endocrine actions of the stem cells in the context of diabetic nephropathy remain to be fully elucidated. The sample size in the animal experiments was relatively small, with a final analysis of four mice per group, which may limit the statistical power of the findings.

This research offers valuable insights into the optimization of stem cell expansion protocols for regenerative medicine. By demonstrating that hypoxic culture can delay senescence and maintain therapeutic potency, the study supports the use of low-oxygen environments in the manufacturing of off-the-shelf cell therapies. The findings highlight the importance of considering the microenvironmental conditions during cell culture to ensure the quality and efficacy of stem cell products.

The study utilized primary human umbilical cord-derived mesenchymal stem cells obtained from Fengzekang Biopharmaceutical Co., Ltd. in Shenzhen, China. These cells were cultured at 37 degrees Celsius with 95% humidity and 5% carbon dioxide, under either 5% oxygen for hypoxic conditions or 20% oxygen for normoxic conditions. The researchers conducted experiments on cells from passages four through sixteen, ensuring that the cells maintained their specific surface marker expression throughout the serial passaging process. Flow cytometry analysis confirmed that the cells consistently expressed positive markers CD29, CD44, CD73, CD90, and CD105, while remaining negative for exclusion markers HLA-DR, CD31, and CD34. This consistent phenotypic profile was observed regardless of the oxygen concentration used during culture, indicating that the hypoxic environment did not alter the fundamental identity of the mesenchymal stem cells during extended expansion.

Transcriptomic analysis of the cells revealed that hypoxia delays senescence by suppressing pro-inflammatory and pro-aging pathways. RNA sequencing identified 11,825 differentially expressed genes between the experimental groups. In high-passage cells cultured under hypoxia, pro-aging mediators such as GPNMB and SQSTM1 were significantly downregulated, while rejuvenation-associated regulators like DUSP2 and HGF were upregulated. Pathway enrichment analysis highlighted significant changes in cell-cycle regulation, cellular senescence, and growth factor secretion. The protein–protein interaction network confirmed the downregulation of senescence-driving proteins, including the cell cycle inhibitor CDKN2A and the NF-κB pathway activator SQSTM1. Conversely, hypoxic cultures showed enhanced expression of vascular endothelial growth factor and fibroblast growth factor, suggesting a maintained paracrine repair capacity that is typically lost in normoxic high-passage cells.

The animal experiments were approved by the Medical Ethics Committee of the First Affiliated Hospital of Shantou University, with ethical approval number SUMC2021-267. Male ICR mice were housed under specific pathogen-free conditions at the Experimental Animal Center of Shantou Medical College. The diabetic nephropathy model was established using a high-fat diet and intraperitoneal injections of streptozotocin for four consecutive days. Mice were considered to have the disease if their blood glucose levels exceeded 16.7 mmol/L and urinary protein levels were significantly elevated. Treatment involved weekly tail vein injections of 200,000 cells in 200 microliters of phosphate-buffered saline for four weeks. The study was conducted by two investigators to minimize bias, with one performing random allocation and the other administering treatments. Anesthesia was maintained using isoflurane, and mice were euthanized by cervical dislocation 24 hours after the final injection for sample collection.

Western blot analysis of kidney tissues further validated the anti-fibrotic effects of hypoxic culture. Treatment with cells expanded at 5% oxygen significantly reduced renal Collagen III and alpha-smooth muscle actin protein levels compared to cells expanded at 20% oxygen. Immunohistochemistry showed that hypoxic high-passage cells markedly attenuated the expression of these fibrogenic markers in the diabetic kidneys. These molecular changes align with the histological observations of reduced collagen deposition and myofibroblast activation. The data suggest that hypoxia preserves the intrinsic ability of the stem cells to limit extracellular matrix deposition, which is a key feature of diabetic kidney disease progression. This preservation of anti-fibrotic efficacy is critical for the potential clinical utility of long-term passaged cell products.

Subject of Research: The impact of hypoxic culture conditions on the senescence and therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in a diabetic nephropathy model.

Article Title: From in vitro to in vivo: hypoxia attenuates replicative senescence and preserves therapeutic activity in long-term passaged human umbilical cord-derived mesenchymal stem cells

Article References: Jia, C., Lin, Z., Zhang, T., He, L., Li, Y., Li, J., Li, X., Zhang, Y., Cai, B., Zou, M., Wu, L., Zhao, X., Ren, C., & Zhang, X. (2026). From in vitro to in vivo: hypoxia attenuates replicative senescence and preserves therapeutic activity in long-term passaged human umbilical cord-derived mesenchymal stem cells. Biological Research, 59(1), Article 44. https://doi.org/10.1186/s40659-026-00703-z

Image Credits: AI Generated

DOI: 10.1186/s40659-026-00703-z

Keywords: mesenchymal stem cells, hypoxia, replicative senescence, diabetic nephropathy, cell culture, regenerative medicine, umbilical cord, therapeutic efficacy, oxidative stress, telomere length, vitro, vivo

News Source: Drew Townsend. (November 12, 2026). Hypoxia Preserves Therapeutic Activity in Long-Term Passaged Stem Cells. Scienmag.

Tags: Cell cultureDiabetic nephropathyhypoxiamesenchymal stem cellsoxidative stressRegenerative Medicinereplicative senescencetelomere lengthTherapeutic Efficacyumbilical cordvitrovivo
Share12Tweet7Share2ShareShareShare1

Related Posts

Molecular Signatures and Signalling Pathways Reveal Precision Targets Across Cerebrovascular Diseases

Molecular Signatures and Signalling Pathways Reveal Precision Targets Across Cerebrovascular Diseases

November 17, 2026
Agricultural Heritage Status Alone Cannot Guarantee Landscape Sustainability, Twenty-Year Review Finds

Agricultural Heritage Status Alone Cannot Guarantee Landscape Sustainability, Twenty-Year Review Finds

November 17, 2026

Adipocyte-specific MC2R overexpression fails to reduce metabolic dysfunction in mice

November 17, 2026

Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

November 17, 2026

POPULAR NEWS

  • Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    Chinese Visceral Adiposity Index Shows Nonlinear Link to Cardiovascular Disease Risk

    29 shares
    Share 12 Tweet 7
  • Review Links Skin Microbiota and T-Cell Crosstalk to Venous Disease Progression

    29 shares
    Share 12 Tweet 7
  • Pre-Curing Rheology Enables Electrospun Silicone Elastomer Coatings for Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Solvothermal Synthesis Yields Bismuth Selenide Nanoparticles with Distinct Phonon Modes

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Self-reports capture more miscarriages than healthcare records in Finnish study

Malpractice Reports for Surgical Never Events Decreased Steadily Over Two Decades

Textile Dyeing Airborne Pollutants and Gene Variants Linked to Rheumatoid Biomarkers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.